Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting #KumpulaPhysics #tiede #tutkimus doi:10.3389/fimmu.2023.1060540 https://t.co/sfTl
13 followers
1,240 followers
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting #HelsinkiHealth #tutkimus #tiede https://t.co/7fUmcItEiZ
18,302 followers
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting https://t.co/HdcVQqlkGC https://t.co/uKd0Ggq82P
33,217 followers
New Research: Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting: Introduction Immune checkpoint inhibitors (ICIs)… https://t.co/iT